TAM
RVLP

Titleist Asset Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Titleist Asset Management’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-100,142
Closed -$8.67K – 241
2023
Q3 		$8.67K Buy
100,142
+12,500
+14% +$3.6K ﹤0.01% 213
2023
Q2 		$49.1K Sell
87,642
-17,361
-17% -$15.3K 0.01% 218
2023
Q1 		$120K Buy
+105,003
New +$126K 0.03% 213

Other funds holding RVLP

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Titleist Asset Management's RVLP Position: Q4 2023 in Review

Titleist Asset Management sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2023, closing a stake of 100,142 shares — an estimated $8.67K sold.

Titleist Asset Management first reported a position in RVLP in Q1 2023 and held it in 3 quarters. The position peaked at $120K in Q1 2023. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.

  • Titleist Asset Management reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Titleist Asset Management sold 100,142 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2023, an estimated $8.67K.
  • Titleist Asset Management first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q1 2023 and held it in 3 quarters.
  • Titleist Asset Management's RVL Pharmaceuticals plc Ordinary Shares position peaked at $120K in Q1 2023.
  • 3 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2023.

Based on Titleist Asset Management's 13F filing for Q4 2023, filed 15 Feb 2024.